# Next Act Fund

> Next Act Fund is a VC fund in Pittsburgh backing Health Care and Therapeutics. See 13 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Pittsburgh, United States
- Total investments: 13
- Last investment: Sep 2021
- Lead investor: 31%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company-beta/16163841/admin/updates/
- X (Twitter): https://twitter.com/NextActFund
- Website: https://www.nextactfund.com/
- Facebook: https://business.facebook.com/pg/NextActFund/posts/

Next Act Fund is a VC fund in Pittsburgh focused on Health Care and Therapeutics. Next Act Fund was founded in 2017 with the intent of investing in early-stage, women-owned/led companies, thereby positively impacting women, the region, and the nation. Next Act Fund, which is the first of its kind in Southwestern Pennsylvania, is also focused on member education, hosting monthly educational sessions open to its members andthe public, as well as a series of educational sessions targeting “future investors”

## Contacts

5 contacts available for Next Act Fund. Shizune tracks 1 team members at Next Act Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/next-act-fund?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $740k–$2.7M |
| Series A | $1.6M–$7.6M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 31% |
| Therapeutics | 3 | 23% |
| Hospital | 2 | 15% |
| Software | 2 | 15% |
| Food and Beverage | 2 | 15% |

34 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 31% |
| Angel | 2 | 15% |
| Series A | 2 | 15% |
| Funding Round | 2 | 15% |
| Private Equity | 1 | 8% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Yvonne Campos | Founder and President | 3 | https://shizune.co/investors/profile/yvonne-campos |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Astarte Medical | Astarte Medical is a clinical intelligence company using software and predictive analytics to improve outcomes for children with medical complexity. Astarte Medical supports standardized care protocols, care planning and decision-making in acute, complex care settings with a suite of digital tools and diagnostics designed to optimize care andoutcomes for vulnerable patient populations when there is great opportunity to impact long-term health. | $7.6M | Series A | Sep 22, 2021 |  |
| Augment Therapy | Augment Therapy is designed by a pediatric physical therapist, Augment Therapy is an all-in-one solution to engage, motivate, and monitor kids needing therapeutic exercise. | $1.4M | Seed | Sep 22, 2021 |  |
| Pomp and Whimsy | Pomp and Whimsy is a winery company that specializes in manufacturing, distribution, and sales of wines and spirits. It features a lightly sweetened and infused spirit that was easier on the palate than the dry gin. | $2.7M | Seed | Jul 12, 2021 |  |
| Performlive | PerformLive is a purpose-driven community for Creators & Sellers to monetize their talent and products via interactive live stream. It combines the power of live interaction, augmented reality, social selling & live commerce, all in one platform. | $740.1K | Seed | Oct 30, 2020 |  |
| Funding U | Funding U is a merit-based student lender for career-focused college students. It offers an alternative to old FICO and cosigner-based bank loan models, and offers loans on the basis of student's academic performance, career trajectory, and earning potential, thus enabling students to apply for loans with fixed interest rates and avoiddropping out of college.It was founded in 2015 and is headquartered in Atlanta, Georgia. | $4M | Private Equity | Oct 29, 2020 |  |
| Lindy Biosciences | Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies),encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​ | $1.6M | Series A | Sep 18, 2019 |  |
| Joylux | Joylux is a health and wellness company that specializes in women's health and wellness. The company is committed to finding scientific solutions that are noninvasive, effective, and affordable to help improve all aspects of a woman’s intimate life. The company was founded in 2013 and headquartered in Seattle, Washington. | $3.7M |  | Sep 06, 2019 |  |
| Pomp and Whimsy | Pomp and Whimsy is a winery company that specializes in manufacturing, distribution, and sales of wines and spirits. It features a lightly sweetened and infused spirit that was easier on the palate than the dry gin. |  | Angel | Sep 06, 2019 |  |
| Time Study | Time Study offers a time intelligence platform that uses machine intelligence to activate and transform enterprise time data into real-time insights on how time is spent and its impact on workforce effectiveness, operational efficiency and compliance. The team is led by 3x entrepreneur and computer scientist Kishau Rogers; she is joined by anexperienced team bringing many years of collective experience growing & building enterprise software solutions. Many of the top US hospitals have selected Time Study as their cloud application for studying how time is spent (at work). | $2.3M | Seed | Sep 01, 2019 |  |
| Astarte Medical | Astarte Medical is a clinical intelligence company using software and predictive analytics to improve outcomes for children with medical complexity. Astarte Medical supports standardized care protocols, care planning and decision-making in acute, complex care settings with a suite of digital tools and diagnostics designed to optimize care andoutcomes for vulnerable patient populations when there is great opportunity to impact long-term health. | $5M | Series A | May 07, 2019 |  |

10 of 13 investments shown.

## Co-investors
- [BlueTree Allied Angels](https://shizune.co/investors/profile/bluetree-allied-angels) — VC Fund, 3 deals together
- [OCA Ventures](https://shizune.co/investors/profile/oca-ventures) — VC Fund, 3 deals together
- [Viking Global Investors](https://shizune.co/investors/profile/viking-global-investors) — VC Fund, 3 deals together
- [37 Angels](https://shizune.co/investors/profile/37-angels) — VC Fund, 2 deals together
- [Ben Franklin Technology Partners of Southeastern Pennsylvania](https://shizune.co/investors/profile/ben-franklin-technology-partners-of-southeastern-pennsylvania) — VC Fund, 2 deals together
- [Golden Seeds](https://shizune.co/investors/profile/golden-seeds) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Imaginary Ventures](https://shizune.co/investors/profile/imaginary-ventures) — VC Fund
- [Distill Ventures](https://shizune.co/investors/profile/distill-ventures) — VC Fund
- [InvestBev](https://shizune.co/investors/profile/investbev) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Wine And Spirits Investors](https://shizune.co/investors/wine-and-spirits-investors)
- [Wine And Spirits Investors in United States](https://shizune.co/investors/wine-and-spirits-investors-united-states)
- [Wine And Spirits VC Funds in United States](https://shizune.co/investors/wine-and-spirits-vc-funds-united-states)
- [Wine And Spirits VC Funds](https://shizune.co/investors/wine-and-spirits-vc-funds)

## FAQ

### What does Next Act Fund invest in?

Next Act Fund invests primarily in Health Care, Therapeutics and Hospital startups, most often at Seed and Angel stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Next Act Fund's check size?

Next Act Fund typically joins rounds of $740k–$2.7M at Seed and $1.6M–$7.6M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Next Act Fund participates in.

### How do I contact Next Act Fund?

Public channels for Next Act Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Next Act Fund?

The team at Next Act Fund includes Yvonne Campos (Founder and President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co